Karl Tully

12PUBLICATIONS
58CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 08, 2026
Impact of Obesity on Systemic Treatment Outcomes in Metastatic Urological Malignancies.

|Mar 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Aleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri

|Mar 03, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Ana Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina

|Aug 29, 2025
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapy.

José Daniel Subiela, Irene de la Parra, Javier Taborda

|Jul 09, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancer.

Markus von Deimling, Marc Furrer, Alberto Bianchi

|May 20, 2025
Functional Outcomes in Patients With Prostate Cancer Undergoing Frozen Section Guided Radical Prostatectomy.

Moritz J Reike, Karl H Tully, Maximilian Schulmeier

Pageof 2

Frequent Collaborators

7 joint publications

Marco Moschini

6 joint publications

Francesco Del Giudice

6 joint publications

Renate Pichler

6 joint publications

Andrea Mari